BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

895 related articles for article (PubMed ID: 9042324)

  • 1. Nm23 expression in breast ductal carcinomas: a ten year follow-up study in a uniform group of node-negative breast cancer patients.
    Kapranos N; Karaiossifidi H; Kouri E; Vasilaros S
    Anticancer Res; 1996; 16(6C):3987-90. PubMed ID: 9042324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between nm23 protein and several cell adhesion molecules in human gastric carcinoma.
    Ura H; Denno R; Hirata K
    Jpn J Cancer Res; 1996 May; 87(5):512-7. PubMed ID: 8641989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retraction: LINC00636 promotes lymph node metastasis and of cervical cancer through target NM23.
    Biosci Rep; 2024 Jan; 44(1):. PubMed ID: 38293727
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and activity of partial retro-inverso analogs of the antimetastatic laminin-derived peptide, YIGSR-NH2.
    Zhao M; Kleinman HK; Mokotoff M
    J Pept Res; 1997 Mar; 49(3):240-53. PubMed ID: 9151257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic globules in Spitz's nevi. New findings and a diagnostic sign.
    Kamino H; Flotte TJ; Misheloff E; Greco MA; Ackerman AB
    Am J Dermatopathol; 1979; 1(4):319-24. PubMed ID: 94511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer vaccines. Part 2.
    Hallin PA; Adams VR
    J Am Pharm Assoc (Wash); 1997; NS37(6):706-9. PubMed ID: 9425801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose intravenous bolus interleukin-2 with interferon-alpha therapy for metastatic melanoma and renal cell carcinoma.
    Karp SE
    J Immunother; 1998 Jan; 21(1):56-61. PubMed ID: 9456437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality of doctors in different specialties: findings from a cohort of 20000 NHS hospital consultants.
    Carpenter LM; Swerdlow AJ; Fear NT
    Occup Environ Med; 1997 Jun; 54(6):388-95. PubMed ID: 9245944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex-vivo gene therapy using cytokine-transduced tumor vaccines: molecular and clinical pharmacology.
    Simons JW; Mikhak B
    Semin Oncol; 1998 Dec; 25(6):661-76. PubMed ID: 9865681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-inactivating protein luffin.
    Poma A; Miranda M; Spanò L
    Melanoma Res; 1998 Oct; 8(5):465-7. PubMed ID: 9835461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of adhesion molecule CD44 in metastatic brain tumors.
    Harabin-Słowińska M; Słowiński J; Konecki J; Mrówka R
    Folia Neuropathol; 1998; 36(3):179-84. PubMed ID: 9833394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin tumor risk among atomic-bomb survivors in Japan.
    Ron E; Preston DL; Kishikawa M; Kobuke T; Iseki M; Tokuoka S; Tokunaga M; Mabuchi K
    Cancer Causes Control; 1998 Aug; 9(4):393-401. PubMed ID: 9794171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic markers, sunlight-related factors and sunscreen use in patients with cutaneous melanoma: an Austrian case-control study.
    Wolf P; Quehenberger F; Müllegger R; Stranz B; Kerl H
    Melanoma Res; 1998 Aug; 8(4):370-8. PubMed ID: 9764814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions.
    Geertsen RC; Hofbauer GF; Yue FY; Manolio S; Burg G; Dummer R
    J Invest Dermatol; 1998 Sep; 111(3):497-502. PubMed ID: 9740247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-2 toxin affects proliferation of three different neoplastic cell lines.
    Juranić Z; Stojiljković MP; Bocarov-Stancić A; Kilibarda V; Milovanović SR; Juranić I; Bijelogrlić S; Vuletić N; Radulović S
    J Exp Clin Cancer Res; 1998 Mar; 17(1):33-40. PubMed ID: 9646231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional ultrasound imaging. Clinical applications.
    Cusumano A; Coleman DJ; Silverman RH; Reinstein DZ; Rondeau MJ; Ursea R; Daly SM; Lloyd HO
    Ophthalmology; 1998 Feb; 105(2):300-6. PubMed ID: 9479291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominance across HLA polymorphism: implications for cancer immunotherapy.
    Kim CJ; Parkinson DR; Marincola F
    J Immunother; 1998 Jan; 21(1):1-16. PubMed ID: 9456431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent melanoma of the leg and polypoid lesions of the gallbladder--a management dilemma.
    Gould SW; Banwell PE; Rosin RD
    Eur J Surg Oncol; 1997 Aug; 23(4):368-9. PubMed ID: 9315071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac metastases from malignant melanoma.
    Gibbs P; Cebon JS; Calafiore P; Robinson WA
    Cancer; 1999 Jan; 85(1):78-84. PubMed ID: 9921977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose adjuvant interferon therapy for melanoma.
    Licata AG
    Dermatol Nurs; 1998 Oct; 10(5):334-6. PubMed ID: 9873271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.